14 Jan 2026
Combining tizanidine and ciprofloxacin can cause dangerous drops in blood pressure and extreme drowsiness due to a powerful drug interaction. Learn why this combo is risky and what to do instead.
11 Jan 2026
Bioequivalent medications are generic drugs proven to work the same as brand-name versions in the body. Learn how regulators test for equivalence, when it matters, and what you should know before switching.
8 Jan 2026
Common medications like Benadryl and oxybutynin can build up anticholinergic burden in older adults, increasing dementia risk. Learn which drugs are dangerous, how they affect the brain, and what safer alternatives exist.
7 Jan 2026
180-day exclusivity under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges. But delays in market entry can block competition for years, keeping prices high for patients.
5 Jan 2026
Biosimilars offer major cost savings and proven safety, but patient hesitation remains high due to misinformation and lack of transparency. Learn how to understand biosimilars, address concerns, and make informed decisions with your doctor.
27 Dec 2025
Understand how insurance formulary tiers work-Tier 1, Tier 2, Tier 3, and non-formulary drugs-and how they affect your prescription costs. Learn what to do when your drug is too expensive.
26 Dec 2025
Learn how to set up medication budgeting and auto-refill alerts to save money, avoid running out of prescriptions, and take control of your healthcare costs with simple, practical steps.
25 Dec 2025
Combination NTI drugs offer powerful treatment for complex conditions but face major barriers to generic availability. Despite high demand, no fixed-dose NTI combinations are approved in the U.S. due to unmet bioequivalence standards, leaving patients at risk and providers with few safe options.
22 Dec 2025
Expired antibiotics may still look fine, but they often lose potency-leading to treatment failure and antibiotic resistance. Learn what really happens after the expiration date and when, if ever, it's safe to use them.
21 Dec 2025
The 180-day exclusivity rule was meant to reward generic drug companies that challenge patents. But brand-name companies can launch their own versions - authorized generics - during that time, undercutting the reward and slowing real competition.
